Navigation Links
AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
Date:9/3/2007

LOS ANGELES, Aug. 28 /PRNewswire-USNewswire/ -- AIDS Healthcare Foundation (AHF) today announced that it is has named Homayoon Khanlou, M.D. as its Chief of Medicine, U.S. Prior to assuming his new role as Chief, Dr. Khanlou served as AHF's Associate Director of Medicine, Regional Medical Director of Western Region, while also holding the posts of AHF's Associate Director of Research and the Medical Director and attending physician for the San Fernando Valley and Antelope Valley Healthcare Centers. Dr. Khanlou has also served as Chair of the Pharmacy and Therapeutic Committee at AHF.

In addition to his extensive experience as a practicing HIV/AIDS physician, Dr. Khanlou is also a leading clinical researcher whose research has been published in such prestigious periodicals as the New England Journal of Medicine and the Archives of Internal Medicine. He is also a featured lecturer at a variety of medical institutions and has spoken the American Academy of Physicians Assistants, Children's Hospital of Los Angeles and a frequent speaker at the Los Angeles Intercity HIV Rounds.

"We are pleased to welcome Dr. Khanlou to the position of AIDS Healthcare Foundation's Chief of Medicine, U.S.," said Michael Weinstein, President of AIDS Healthcare Foundation. "In the eight years that Dr. Khanlou has been serving AHF patients, he has demonstrated noteworthy passion in providing the highest-quality medical care to his patients. To the position of Chief, Dr. Khanlou brings not only this dedication to excellence in patient care, but also his extensive experience as a top physician in the field and as a highly- regarded researcher and lecturer with deep knowledge of the latest in HIV/AIDS medicine. As our U.S. healthcare operations continue to expand, providing cutting-edge medical care to those in need, all of us at AHF look forward to working with Dr. Khanlou in this new leadership role."

Dr. Khanlou has practiced in a wide variety of medical communities i
'/>"/>

SOURCE AIDS Healthcare Foundation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
2. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
3. Nationwide MRSA Prevalence Study to Demonstrate Full Scope of Superbug Threat Facing U.S. Healthcare Facilities and Patients
4. FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations, FDA Regulations
5. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
6. Over 10,000 UK Breast Cancer Patients Could Become Eligible Within the Next Year for a Breast Cancer Therapy Showing Increased Survival Rates, Reveals Synovate Healthcare’s European Oncology Monitor
7. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
8. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
9. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
10. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
11. The International Myeloma Foundation Reports Positive Shift In Treatment Paradigm For Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...6 /- Complete,Genomics Inc., a newly ...,company, and the Institute for Systems Biology (I...opulationwide human genome studies., In phase one...oprietary,DNA sequencing technology to sequence fi...e proof-of-concept has been demonstrated, ISB and ...
(Date:10/6/2008)...f Naltrexone SR Associated with Bet...ct. 6 /- Orexigen Therapeut...mpany focused on the treatment of,obesity and othe...presented,data showing the investigational drug, C...fully achieved key objectives (lowered naltrexone,...
(Date:10/6/2008)...,s Bioabsorbable Stent - Also,Slated for Presentat...-- Data from multiple clinical trials of,the world...o-engineered R,stent, will be presented next week ...ymposium, TCT 2008, in Washington, D.C., Robbert ...nter in,Amsterdam will provide a Genous clinical p...
(Date:10/3/2008)...est study site, PHILADELPHIA, Oct. 3 /PRNewswire-...phia today received a contract to manage a new stu...,s Hospital will manage local,participation, recru...ew,Jersey. The study is funded by the National Ins...oximately 1,000 families in Burlington,County will...
Breaking Medicine Technology:Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2The American Society for Aesthetic Plastic Surgery Addresses the Safety of Botox 10172 1The American Society for Aesthetic Plastic Surgery Addresses the Safety of Botox 10172 2American Society for Dermatologic Surgery Supports Current Labeling of Allergans Botox 28R 29 Products 10170 1American Society for Dermatologic Surgery Supports Current Labeling of Allergans Botox 28R 29 Products 10170 2Therapist to Young Hollywood Says Industry Needs to Take More Responsibility for Protecting Stars Mental Health 10168 1Therapist to Young Hollywood Says Industry Needs to Take More Responsibility for Protecting Stars Mental Health 10168 2Making the Most Out of Your Doctors Visit 10166 1Making the Most Out of Your Doctors Visit 10166 2
...ential to Demonstrate an Effect,on a Serious or Li...y 07, 2007 /PRNewswire-FirstCall/ -- Cell,Therapeu...track,designation from the U.S. Food and Drug Admi...edione, being investigated for the,potential treat...n,s lymphoma (NHL). In granting fast track, the FD...
...ne Glycol,(DEG) Remains a Potential Health Hazard ...U.S. Food and Drug,Administration (FDA) is warning...ackers, and health professionals who compound,medi... glycerin, a,sweetener commonly used worldwide in ...ucts, is not contaminated with diethylene,glycol (...
Other Medicine Technology:Pixantrone Granted Fast Track Designation by FDA for Relapsed,Indolent NHL Patients 2Pixantrone Granted Fast Track Designation by FDA for Relapsed,Indolent NHL Patients 3Pixantrone Granted Fast Track Designation by FDA for Relapsed,Indolent NHL Patients 4Pixantrone Granted Fast Track Designation by FDA for Relapsed,Indolent NHL Patients 5FDA Advises Manufacturers to Test Glycerin for Possible,Contamination 2
(Date:10/7/2008)... Licensed Chiropractor Dr. Richard A. ... Newburgh, NY (Vocus) October 7, 20...one of the most stressful times in its history. H...ng costs of everything from phone bills to electri...creased stress. And with growing stress levels co...
(Date:10/7/2008)... Mickie Bellah,s Luminescence Series p...International Fine Art Gallery in the Chelsea Dist...Austin, TX (PRWEB) October 7, 2008 -- Austin Artis...ning of her Luminescence Series paintings at Amste... Chelsea District of New York City,October 10, 200...
(Date:10/6/2008)...s sold not helping fight against childhood obesity...(HealthDay News) -- Three-quarters of middle schoo...drinks are sold, a new study finds. , The resea...n most middle schools, and "that those vending mac...aid study author Amy Virus, a registered dietitian...
(Date:10/6/2008)..., Oct. 6 /PRNewswire-FirstCall/ -- Volcano Corpora..., manufacturing and sales of,products for the diag...ery,disease, today announced the relocation of its... Rancho Cordova to San Diego. The new corporate,he... San Diego and now,houses corporate executives, ma...
Breaking Medicine News(10 mins):Health News:Prescriptions for Stress 2Health News:Prescriptions for Stress 3Health News:Vending Machines Found in Most Middle Schools 2Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 2Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 3Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 4
... Respiratory and Critical Care Medicine says that ... in the blood could// help detect abnormal lesions...arker of inflammation and measuring the blood leve...ople at risk for developing lesions that could cau...
...nd after the health authorities promised to pay at...ding their safety and working hours//. As word sp... of patients poured into the hospitals. Long queue...ospitals. 'It could not have come at a better tim...
...ions of the oral cavity can be effectively treated...archers from the University at Buffalo's School of...y employed in cancer treatment. PDT is currently e...arcoma, breast cancer (spread to the chest wall) a...
...rd flu, it has been proposed to construct military...ovide the best help in the avian influenza fight. ...ished in the internationally acclaimed Nature jour...hrough co-ordination between such international la...
Other Medicine News:Health News:Infections Of The Oral Cavity Can Be Treated By Photodynamic Therapy 2
1 x 2 teeth, cross serrated 5 mm 60 degree angled platform. Round knurled handle with polished finish.
Narrow 4 mm long smooth platform. Serrated handle with polished finish.
1 mm smooth 45 degrees angled jaws. Cross action serrated handle with polished finish.
Oval solid 16 mm wide lower plate. Open upper plate with inside dimensions 12 mm x 14 mm. Serrated handle with locking thumb screw and polished finish.
Medicine Products: